511 related articles for article (PubMed ID: 28220931)
1. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
[TBL] [Abstract][Full Text] [Related]
2. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
7. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
8. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis: how, when, and why.
Ward DM
J Clin Apher; 2011; 26(5):276-85. PubMed ID: 21898572
[TBL] [Abstract][Full Text] [Related]
14. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis in pediatric patients: Practical and technical considerations.
DeSimone RA; Schwartz J; Schneiderman J
J Clin Apher; 2017 Dec; 32(6):543-552. PubMed ID: 28304115
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature.
Das-Gupta E; Dignan F; Shaw B; Raj K; Malladi R; Gennery A; Bonney D; Taylor P; Scarisbrick J
Bone Marrow Transplant; 2014 Oct; 49(10):1251-8. PubMed ID: 24887389
[TBL] [Abstract][Full Text] [Related]
17. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
[No Abstract] [Full Text] [Related]
18. [Extracorporeal photopheresis].
Hsieh A; Cortés B
Rev Med Suisse; 2018 Mar; 14(600):699-702. PubMed ID: 29589657
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.
Dunbar NM; Raval JS; Johnson A; Abikoff CM; Adamski J; Cooling LL; Grossman B; Kim HC; Marques MB; Morgan S; Schmidt AE; Sloan SR; Su LL; Szczepiorkowski ZM; West FB; Wong E; Schneiderman J
J Clin Apher; 2017 Aug; 32(4):215-223. PubMed ID: 27442906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
